{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:14:34Z","timestamp":1787242474443,"version":"build-2736575974"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Biotechnology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.copbio.2026.103440","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T13:09:23Z","timestamp":1769432963000},"page":"103440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Engineering microbial therapeutics for metabolic disorders: synthetic biology strategies and future direction"],"prefix":"10.1016","volume":"98","author":[{"given":"Yani","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongmin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.copbio.2026.103440_sbref1","first-page":"39","article-title":"Global prevalence of metabolic disorders, associated factors and management","volume":"10","author":"Aanuoluwa","year":"2025","journal-title":"Int J Health Pharm Res"},{"key":"10.1016\/j.copbio.2026.103440_bib2","unstructured":"World Health Organization W. WHO updates list of essential medicines to include key cancer, diabetes treatments: World Health Organization; 2025 [updated 5 September 2025; cited 2025 28th November 2025]. Available from: \u3008https:\/\/www.who.int\/news\/item\/05\u201309-2025-who-updates-list-of-essential-medicines-to-include-key-cancer--diabetes-treatments\u3009."},{"key":"10.1016\/j.copbio.2026.103440_bib3","unstructured":"World Health Organization W. Urgent action needed as global diabetes cases increase four-fold over past decades: World Health Organization; 2024 [updated 13 Novemeber 2024; cited 2025 28 November 2025]. Available from: \u3008https:\/\/www.who.int\/news\/item\/13\u201311-2024-urgent-action-needed-as-global-diabetes-cases-increase-four-fold-over-past-decades\u3009."},{"key":"10.1016\/j.copbio.2026.103440_bib4","unstructured":"World Health Organization W. Diabetes: World Health Organization; 2024 [updated 14 November 2024; cited 2025 28 November 2025]. Available from: \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes\u3009."},{"key":"10.1016\/j.copbio.2026.103440_bib5","article-title":"Design of a novel long-acting insulin analogs by acetylation modification and compared with insulin Icodec","volume":"15","author":"Yu","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.copbio.2026.103440_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e40265","article-title":"Therapeutic peptide development revolutionized: harnessing the power of artificial intelligence for drug discovery","volume":"10","author":"Hashemi","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.copbio.2026.103440_bib7","article-title":"Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines","volume":"10","author":"Xiao","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.copbio.2026.103440_bib8","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.tibtech.2022.09.014","article-title":"Creativebiological lignin conversion routes toward lignin valorization","volume":"40","author":"Liu","year":"2022","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.copbio.2026.103440_bib9","article-title":"Multiscalemetabolic engineering in biological lignin valorization","volume":"6","author":"Liu","year":"2025","journal-title":"Innovation"},{"key":"10.1016\/j.copbio.2026.103440_sbref7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tem.2024.04.021","article-title":"Advanced microbiome therapeutics as a novel modality for oral delivery of peptides to manage metabolic diseases","volume":"36","author":"Vazquez-Uribe","year":"2025","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.copbio.2026.103440_sbref8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40265-024-02107-3","article-title":"The future of microbiome therapeutics","volume":"85","author":"Pitashny","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.copbio.2026.103440_bib12","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.7150\/thno.103983","article-title":"Engineered probiotic-based biomaterials for inflammatory bowel disease treatment","volume":"15","author":"Sang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.copbio.2026.103440_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26125486","article-title":"Gut microbiota-targeted therapeutics for metabolic disorders: mechanistic insights into the synergy of probiotic-fermented herbal bioactives","volume":"26","author":"Fan","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.copbio.2026.103440_bib14","article-title":"Therapeutic potential of probiotics in metabolic dysfunction-associated steatohepatitis: a comprehensive review","volume":"13","author":"Wang","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.copbio.2026.103440_sbref12","doi-asserted-by":"crossref","DOI":"10.1155\/cjid\/6675676","article-title":"Administration of a next-generation probiotic Escherichia coli Nissle 1917-GLP-1 alleviates diabetes in mice with type 1 and type 2 diabetes","volume":"2025","author":"Luo","year":"2025","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.copbio.2026.103440_bib16","article-title":"The role of Lactobacillus plantarum in reducing obesity and inflammation: a meta-analysis","volume":"25","author":"Li","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.copbio.2026.103440_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1425764","article-title":"Lactobacillus plantarum alleviates high-fat diet-induced obesity by altering the structure of mice intestinal microbial communities and serum metabolic profiles","volume":"15","author":"Zhu","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.copbio.2026.103440_sbref15","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.3168\/jds.2024-26193","article-title":"PYY-mediated appetite control and obesity alleviation through short-chain fatty acid\u2013driven gut-brain axis modulation by Lacticaseibacillus rhamnosus HF01 isolated from Qula","volume":"108","author":"Sun","year":"2025","journal-title":"J Dairy Sci"},{"key":"10.1016\/j.copbio.2026.103440_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202300927","article-title":"Postbiotics prepared using Lactobacillus reuteri ameliorates ethanol-induced liver injury by regulating the FXR\/SHP\/SREBP-1c axis","volume":"68","author":"Liu","year":"2024","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.copbio.2026.103440_bib20","doi-asserted-by":"crossref","first-page":"10917","DOI":"10.2147\/IJN.S492651","article-title":"Engineering probiotics for diabetes management: advances, challenges, and future directions in translational microbiology","volume":"19","author":"Zhang","year":"2024","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.copbio.2026.103440_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2447814","article-title":"Hypoglycemic effect of C. butyricum-pMTL007-GLP-1 engineered probiotics on type 2 diabetes mellitus","volume":"17","author":"Zhou","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.copbio.2026.103440_sbref19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26136408","article-title":"Heat-inactivated Pediococcus acidilactici pA1c\u00aeHI maintains glycemic control and prevents body weight gain in high-fat-diet-fed mice","volume":"26","author":"Cabello-Olmo","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.copbio.2026.103440_sbref20","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2024.112565","article-title":"Lactobacillus plantarum NCHBL-004 modulates high-fat diet\u2013induced weight gain and enhances GLP-1 production for blood glucose regulation","volume":"128","author":"Jang","year":"2024","journal-title":"Nutrition"},{"key":"10.1016\/j.copbio.2026.103440_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00965-25","article-title":"Multi-omics analysis reveals the mechanism of Lactobacillus plantarum in alleviating metabolic disorders in type 2 diabetic mice through the gut-liver axis","volume":"10","author":"Zhang","year":"2025","journal-title":"mSystems"},{"key":"10.1016\/j.copbio.2026.103440_bib25","first-page":"1","article-title":"Synergistic effects of human-origin novel postbiotic Bacteroides & Phocaeicola on obesity and thermogenesis in high-fat diet-induced metabolic dysfunction","volume":"13","author":"Wu","year":"2025","journal-title":"Benef Microbes"},{"key":"10.1016\/j.copbio.2026.103440_bib26","article-title":"Recent advances in gut microbiota-mediated regulation of fat deposition and metabolic disorders","volume":"4","author":"Cui","year":"2025","journal-title":"Micro Res Rep"},{"key":"10.1016\/j.copbio.2026.103440_bib27","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.3390\/foods13182992","article-title":"Probiotics and non-alcoholic fatty liver disease: unveiling the mechanisms of Lactobacillus plantarum and Bifidobacterium bifidum in modulating lipid metabolism, inflammation, and intestinal barrier integrity","volume":"13","author":"Lu","year":"2024","journal-title":"Foods"},{"key":"10.1016\/j.copbio.2026.103440_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122970","article-title":"Remolding probiotics for effective treatment of type 2 diabetes via oral administration","volume":"315","author":"Ji","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.copbio.2026.103440_bib29","article-title":"Bile salt hydrolase: a key player in gut microbiota and its implications for metabolic dysfunction-associated steatotic liver disease","volume":"4","author":"Zhao","year":"2025","journal-title":"Micro Res Rep"},{"key":"10.1016\/j.copbio.2026.103440_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2531198","article-title":"Programmable probiotic consortium employ an oleic acid-inducible system to sense and degrade cholesterol in high-fat diet mice","volume":"17","author":"Yang","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.copbio.2026.103440_sbref28","article-title":"Probiotic-based materials as living therapeutics","author":"Sabio","year":"2025","journal-title":"Adv Mater"},{"key":"10.1016\/j.copbio.2026.103440_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/acssynbio.4c00399","article-title":"Engineered Bacillus subtilis as oral probiotics to enhance clearance of blood lactate","volume":"14","author":"Yang","year":"2025","journal-title":"ACS Synth Biol"},{"key":"10.1016\/j.copbio.2026.103440_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1366017","article-title":"Engineered probiotic cocktail with two cascade metabolic Escherichia coli for the treatment of hyperlysinemia","volume":"15","author":"Geng","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.copbio.2026.103440_bib34","doi-asserted-by":"crossref","DOI":"10.59717\/j.xinn-life.2024.100082","article-title":"Gut-to-brain neuromodulation by synthetic butyrate-producing commensal bacteria","volume":"2","author":"Wang","year":"2024","journal-title":"Innov Life"},{"key":"10.1016\/j.copbio.2026.103440_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2300847","article-title":"Bifidobacterium alleviate metabolic disorders via converting methionine to 5\u2032-methylthioadenosine","volume":"16","author":"Lyu","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.copbio.2026.103440_bib36","doi-asserted-by":"crossref","DOI":"10.1186\/s13036-025-00479-y","article-title":"Engineering probiotic Escherichia coli for inflammation-responsive indoleacetic acid production using RiboJ-enhanced genetic circuits","volume":"19","author":"Woo","year":"2025","journal-title":"J Biol Eng"},{"key":"10.1016\/j.copbio.2026.103440_sbref34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41564-025-02197-z","article-title":"Gut microbiome-mediated transformation of dietary phytonutrients is associated with health outcomes","volume":"11","author":"Zhang","year":"2026","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.copbio.2026.103440_sbref35","doi-asserted-by":"crossref","first-page":"8202","DOI":"10.1039\/D4CS00196F","article-title":"Navigating the landscape of enzyme design: from molecular simulations to machine learning","volume":"53","author":"Zhou","year":"2024","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.copbio.2026.103440_sbref36","article-title":"Accelerating enzyme discovery and engineering with high-throughput screening","author":"Bozkurt","year":"2024","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.copbio.2026.103440_bib40","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1002\/bit.28770","article-title":"Enhancing cell-based therapies with synthetic gene circuits responsive to molecular stimuli","volume":"121","author":"Galvan","year":"2024","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.copbio.2026.103440_bib41","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.tibtech.2023.09.010","article-title":"Synthetic transcription factor engineering for cell and gene therapy","volume":"42","author":"Bhatt","year":"2024","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.copbio.2026.103440_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s12934-024-02302-7","article-title":"Discovery of a high-performance phage-derived promoter\/repressor system for probiotic lactobacillus engineering","volume":"23","author":"Blanch-Asensio","year":"2024","journal-title":"Microb Cell Factor"},{"key":"10.1016\/j.copbio.2026.103440_bib43","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.synbio.2024.02.003","article-title":"Construction of a broad-host-range Anderson promoter series and particulate methane monooxygenase promoter variants expand the methanotroph genetic toolbox","volume":"9","author":"Bhat","year":"2024","journal-title":"Synth Syst Biotechnol"},{"key":"10.1016\/j.copbio.2026.103440_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymben.2024.08.001","article-title":"Genetic heterogeneity of engineered Escherichia coli Nissle 1917 strains during scale-up simulation","volume":"85","author":"Munkler","year":"2024","journal-title":"Metab Eng"},{"key":"10.1016\/j.copbio.2026.103440_sbref42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108336","article-title":"Next generation probiotics: engineering live biotherapeutics","volume":"72","author":"Murali","year":"2024","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.copbio.2026.103440_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-024-03356-y","article-title":"Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Pan","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.copbio.2026.103440_bib47","article-title":"The role of Lactobacillus plantarum in reducing obesity and inflammation: a meta-analysis","volume":"25","author":"Li","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.copbio.2026.103440_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bidere.2025.100039","article-title":"Recent advances of engineered probiotics for therapeutic applications","volume":"7","author":"Zhang","year":"2025","journal-title":"BioDesign Res"},{"key":"10.1016\/j.copbio.2026.103440_bib49","article-title":"Potential applications of engineered bacteria in disease diagnosis and treatment","volume":"4","author":"Zhaowei","year":"2024","journal-title":"Micro Res Rep"},{"key":"10.1016\/j.copbio.2026.103440_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2024.106028","article-title":"Lactiplantibacillus plantarum L67 reduces diet-induced obesity by stimulating gene programming for adipose lipolysis and energy expenditure","volume":"113","author":"Hong","year":"2024","journal-title":"J Funct Foods"},{"key":"10.1016\/j.copbio.2026.103440_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/metabo14010044","article-title":"Genetic circuits for feedback control of gamma-aminobutyric acid biosynthesis in probiotic Escherichia coli Nissle 1917","volume":"14","author":"Lebovich","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/j.copbio.2026.103440_bib52","doi-asserted-by":"crossref","DOI":"10.1007\/s00203-025-04417-w","article-title":"Therapeutic engineering of the gut microbiome using synthetic biology and metabolic tools: a comprehensive review with E. coli Nissle 1917 as a model case study","volume":"207","author":"Sadhu","year":"2025","journal-title":"Arch Microbiol"},{"key":"10.1016\/j.copbio.2026.103440_bib53","article-title":"Short-chain fatty acids in nonalcoholic fatty liver disease: new prospects for short-chain fatty acids as therapeutic targets","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.copbio.2026.103440_bib54","article-title":"Altered gut microbial profile accompanied by abnormal short chain fatty acid metabolism exacerbates nonalcoholic fatty liver disease progression","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.copbio.2026.103440_bib55","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.freeradbiomed.2024.12.013","article-title":"A bioadhesive antioxidase-overexpressed probiotic prevents radiation enteritis by scavenging the excess reactive oxygen species","volume":"227","author":"Wang","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.copbio.2026.103440_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13080985","article-title":"Gut microbiota dysbiosis, oxidative stress, inflammation, and epigenetic alterations in metabolic diseases","volume":"13","author":"Mostafavi Abdolmaleky","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.copbio.2026.103440_bib57","article-title":"Unlocking gut-liver-brain axis communication metabolites: energy metabolism, immunity and barriers","volume":"10","author":"Sun","year":"2024","journal-title":"npj Biofilms Micro"},{"key":"10.1016\/j.copbio.2026.103440_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2025.107931","article-title":"Synthetic biology approaches for restoring gut microbial balance and engineering disease-specific microbiome therapeutics","volume":"207","author":"Mkilima","year":"2025","journal-title":"Micro Pathog"},{"key":"10.1016\/j.copbio.2026.103440_bib59","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.4014\/jmb.2407.07004","article-title":"Synthetic biology-driven microbial therapeutics for disease treatment","volume":"34","author":"Kim","year":"2024","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.copbio.2026.103440_bib60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12038-025-00531-5","article-title":"Postbiotic potential of SCFAs on metaflammation and gut microbiota alteration in diabetes","volume":"50","author":"Mandaliya","year":"2025","journal-title":"J Biosci"},{"key":"10.1016\/j.copbio.2026.103440_sbref58","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1038\/s41467-025-58319-y","article-title":"SCFA biotherapy delays diabetes in humanized gnotobiotic mice by remodeling mucosal homeostasis and metabolome","volume":"16","author":"Tillett","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.copbio.2026.103440_bib62","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83690","article-title":"Metabolic model-based ecological modeling for probiotic design","volume":"13","author":"Brunner","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.copbio.2026.103440_bib63","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf693","article-title":"A quorum sensing-controlled type I CRISPRi toolkit for dynamically regulating metabolic flux","volume":"53","author":"Zheng","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.copbio.2026.103440_bib64","article-title":"Innovative applications and research advances of bacterial biosensors in medicine","volume":"16","author":"Liu","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.copbio.2026.103440_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1511149","article-title":"Advancing microbiota therapeutics: the role of synthetic biology in engineering microbial communities for precision medicine","volume":"12","author":"Nazir","year":"2024","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.copbio.2026.103440_bib66","doi-asserted-by":"crossref","DOI":"10.1007\/s40200-025-01694-6","article-title":"Probiotics and functional foods in metabolic disease: emerging solutions for obesity and diabetes","volume":"24","author":"Maqsood","year":"2025","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.copbio.2026.103440_bib67","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-024-03356-y","article-title":"Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Pan","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.copbio.2026.103440_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103921","article-title":"Potential of postbiotics for the treatment of metabolic disorders","volume":"29","author":"Mishra","year":"2024","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.copbio.2026.103440_sbref66","article-title":"A synthetic hyperglycemia\u2013sensing gene circuit enhances blood glucose homeostasis in diabetic mice","volume":"S1525-0016","author":"Zhang","year":"2026","journal-title":"Mol Ther"},{"key":"10.1016\/j.copbio.2026.103440_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2025.100265","article-title":"Microbiota-derived bile acid metabolic enzymes and their impacts on host health","volume":"4","author":"Ma","year":"2025","journal-title":"Cell Insight"},{"key":"10.1016\/j.copbio.2026.103440_sbref68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.copbio.2026.103440_bib72","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-024-01900-7","article-title":"Potential probiotic Lactiplantibacillus plantarum strains alleviate TNF-\u03b1 by regulating ADAM17 protein and ameliorate gut integrity through tight junction protein expression in in vitro model","volume":"22","author":"Devi","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.copbio.2026.103440_sbref70","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1038\/s41467-025-62569-1","article-title":"Probiotic acoustic biosensors for noninvasive imaging of gut inflammation","volume":"16","author":"Buss","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.copbio.2026.103440_bib74","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-025-09021-y","article-title":"Custom CRISPR\u2013Cas9 PAM variants via scalable engineering and machine learning","volume":"643","author":"Silverstein","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.copbio.2026.103440_bib75","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.molcel.2025.09.020","article-title":"Tuning insulin receptor signaling using de novo-designed agonists","volume":"85","author":"Wang","year":"2025","journal-title":"Mol Cell"},{"key":"10.1016\/j.copbio.2026.103440_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/INMD.20240075","article-title":"Metabolic diseases and interferon immune responses","volume":"3","author":"Zhou","year":"2025","journal-title":"Interdiscip Med"},{"key":"10.1016\/j.copbio.2026.103440_bib77","doi-asserted-by":"crossref","DOI":"10.1111\/1751-7915.70080","article-title":"Engineered bacteria for disease diagnosis and treatment using synthetic biology","volume":"18","author":"Jin","year":"2025","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.copbio.2026.103440_bib78","article-title":"Chemically and biologically engineered bacteria-based delivery systems for emerging diagnosis and advanced therapy","volume":"33","author":"Li","year":"2021","journal-title":"Adv Mater"}],"container-title":["Current Opinion in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166926000054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166926000054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:12:49Z","timestamp":1773983569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958166926000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":78,"alternative-id":["S0958166926000054"],"URL":"https:\/\/doi.org\/10.1016\/j.copbio.2026.103440","relation":{},"ISSN":["0958-1669"],"issn-type":[{"value":"0958-1669","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering microbial therapeutics for metabolic disorders: synthetic biology strategies and future direction","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.copbio.2026.103440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103440"}}